Literature DB >> 8071597

Gene therapy: current status and future prospects.

W G Kerr1, J J Mulé.   

Abstract

The ability to successfully introduce foreign genes into eukaryotic cells has made possible a new approach to the treatment of human disease. Gene therapy is now being brought to bear on genetic, malignant, and infectious diseases. In this review, we summarize the status of the field through an analysis of clinical protocols involving transfer of marker or therapeutic gene(s) into various somatic cell targets. Many of these trials will begin to examine whether or not patients with diseases that are unresponsive to conventional therapeutic interventions (e.g., pharmaceutical, surgical) will show benefit solely from somatic cell-based gene therapies. In other trials, the gene therapies are meant to complement or bolster the effect of conventional treatments. Although the field of gene therapy is now entering the clinical arena, we will also attempt to summarize certain shortcomings and technical hurdles that will need to be overcome for its eventual widespread use.

Entities:  

Mesh:

Year:  1994        PMID: 8071597     DOI: 10.1002/jlb.56.2.210

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

Review 1.  Nonviral gene transfer strategies for the vasculature.

Authors:  Jennifer L Young; David A Dean
Journal:  Microcirculation       Date:  2002-01       Impact factor: 2.628

Review 2.  Current aspects of gene therapy: implications for vascular interventions.

Authors:  F Reifers; J Kreuzer
Journal:  J Mol Med (Berl)       Date:  1995-12       Impact factor: 4.599

3.  High-level gene transfer to the cornea using electroporation.

Authors:  Kathleen Blair-Parks; Bonnie C Weston; David A Dean
Journal:  J Gene Med       Date:  2002 Jan-Feb       Impact factor: 4.565

4.  Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo.

Authors:  R C Fields; K Shimizu; J J Mulé
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

5.  Generation of retroviruses for the overexpression of cytosolic and mitochondrial glutathione reductase in macrophages in vivo.

Authors:  Marta Kisgati; Reto Asmis
Journal:  Cytotechnology       Date:  2007-02-23       Impact factor: 2.058

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.